Results 111 to 120 of about 33,519 (179)

Low Incidence of Anti-PF4/Heparin Antibodies in Patients with Acute Myelogenous Leukemia. [PDF]

Mediterr J Hematol Infect Dis
Sørvoll IH, Lægreid IJ, Sollid T, Ahlen MT, Johansen S, Reikvam H.   +5 more
europepmc   +1 more source

Development of E-ice-COLD-PCR assay combined with HRM analysis for Nucleophosmin1 gene mutation detection in acute myelogenous leukemia. [PDF]

PLoS One, 2022
Kongta R, Panyasit N, Jansaento W, Duangmano S.   +3 more
europepmc   +1 more source

Breaking the Bone Marrow Barrier: Peripheral Blood as a Gateway to Measurable Residual Disease Detection in Acute Myelogenous Leukemia. [PDF]

Am J Hematol
Butler JT, Yashar WM, Swords R.
europepmc   +1 more source

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes. [PDF]

Cells, 2022
Skalska-Bugala A, Starczak M, Szukalski Ł, Gawronski M, Siomek-Gorecka A, Szpotan J, Labejszo A, Zarakowska E, Szpila A, Jachalska A, Szukalska A, Kruszewski M, Sadowska A, Wasilow A, Baginska P, Czyz J, Olinski R, Rozalski R, Gackowski D.   +18 more
europepmc   +1 more source

A lncRNA signature associated with endoplasmic reticulum stress supports prognostication and prediction of drug resistance in acute myelogenous leukemia. [PDF]

Transl Cancer Res
Fu Y, Wang S, Meng L, Liu Y.
europepmc   +1 more source

Histological Remission of Eosinophilic Esophagitis Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia. [PDF]

Cureus
Méndez G, Griggs T, Ludi D, Yazici C, Yeon SY.   +4 more
europepmc   +1 more source

Evaluate the Efficacy of Myeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia at BTH, Vietnam. [PDF]

Int J Hematol Oncol Stem Cell Res
Nguyen TH, Huynh HT, Tran HQ, Nguyen QT, Huynh PDV, Hoang ND, Ma TX, Thuy Do DT, Phu DC, Huynh MV.   +9 more
europepmc   +1 more source

Atypical Peripheral Retinal Necrosis Without Ocular Inflammation and Retinal Whitening in a Patient With Acute Myelogenous Leukemia: A Case Report. [PDF]

Cureus
Nakagawa Y, Tan X, Yoshida H, Suzuki T, Suzuki Y.   +4 more
europepmc   +1 more source

Statement of Retraction: MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4. [PDF]

Bioengineered
europepmc   +2 more sources

[Acute myelogenous leukemia].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1969
P, Stavem, P F, Hjort
openaire   +1 more source